Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.
Tell us about a missing company
Renovo clinical trials
The registry lists 30 studies whose lead sponsor is Renovo. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Mar 3, 2011.
Registry sponsor names on this page
Each name exactly as ClinicalTrials.gov lists it, and how it relates to Renovo.
- Renovo30 studiesSame company
Something wrong?
Focus areas
Conditions Renovo leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.
Studies
Recruiting first, then most recently updated. Showing 30 of 30.
- Juvista in Scar Revision Surgery of Disfiguring ScarsCompletedNCT00742443Phase 3
- Prevascar in African Continental Group ScarringStatus unknownNCT01115868Phase 1
- Adaprev in Digital Flexor Tendon RepairStatus unknownNCT01014494Not applicable
- A Trial to Compare the Efficacy of Two Formulations of Avotermin Against PlaceboCompletedNCT01029158Phase 1
- Exploratory Study of the Efficacy and Safety of Juvista 250ng When Administered Following Excision of Ear Lobe KeloidsCompletedNCT00836147Phase 1/2
- Juvista (Avotermin) in Scars Following Varicose Vein RemovalCompletedNCT00430326Phase 2
- Juvista in the Non-surgical Improvement of Existing ScarsWithdrawnNCT00821457Not applicable
- Safety of Juvista When Administered Following Excision of Ear Lobe KeloidsCompletedNCT00710333Phase 1/2
- Investigation of the Efficacy of Zesteem in Accelerating Early Wound HealingCompletedNCT00984386Phase 2
- Investigation Into the Safety and Scar-improvement Efficacy of Intradermal Juvidex Dosed Once or Three TimesCompletedNCT00984516Phase 2
- Investigation Into the Scar Reduction Potential of Prevascar (Interleukin-10)CompletedNCT00984646Phase 2
- Safety and Efficacy Study of Avotermin (Juvista) in Female SubjectsCompletedNCT00984581Phase 1/2
- Investigation of the Accelerated Healing and Anti-scarring Potential of Avotermin (Juvista) in Split Skin Graft Donor SitesCompletedNCT00984503Phase 2
- Investigation Into the Safety of Intradermal Juvidex (M6P) Administered to Wounds of Healthy SubjectsCompletedNCT00984854Phase 1
- Investigation of the Safety, Dosing Frequency and Anti-Scarring Potential of Two Concentrations of Intradermal Avotermin (Juvista)CompletedNCT00978367Phase 1/2
- Trial of Juvista (Avotermin) Following Removal of Ear Lobe Keloid ScarsCompletedNCT00469235Phase 1/2
- Safety Study of Repeated, Escalating Doses of Intradermal Avotermin (Juvista)CompletedNCT00978302Phase 1
- Genomic Changes Associated With the Use of Intradermal Avotermin (Juvista) in Small Wounds in Healthy Male SubjectsCompletedNCT00977951Phase 1/2
- Trial of Zesteem (Estradiol) in Healing of Split Thickness Skin Graft Donor SitesCompletedNCT00426972Phase 3
- Safety and Efficacy of RN1001(Avotermin) in Healthy Male SubjectsCompletedNCT00847925Phase 1/2
- Efficacy and Safety of Intradermal RN1001 (Avotermin) in Elderly Subjects.CompletedNCT00847795Phase 1/2
- Juvista (Avotermin) in the Prevention or Improvement of Scar Appearance Following Scar Revision Surgery.Status unknownNCT00432211Phase 2
- Juvista (Avotermin) in Breast Reduction Surgery ScarsTerminatedNCT00432328Phase 2
- Pharmacogenomic Analysis of Samples From Subjects in Study RN1004-0082CompletedNCT00663780
- Juvidex (Mannose-6-Phosphate) in Accelerating the Healing of Split Thickness Skin Graft Donor SitesCompletedNCT00664352Phase 1/2
- RN1001(Avotermin) in Scar Improvement Following Breast AugmentationCompletedNCT00436449Phase 2
- A Trial to Investigate Scar Improvement Efficacy of RN1001 (Avotermin) After Head and Neck Naevi ExcisionStatus unknownNCT00656227Phase 2
- Improvement in Scar Appearance Following Injection of Avotermin (Juvista) Into Skin Incisions Made in Healthy Men and WomenCompletedNCT00629811Phase 2
- Scar-Improvement Efficacy and Safety of a Single Intradermal Injection of Avotermin (Juvista) Administered Following Full-Thickness Skin IncisionsCompletedNCT00627536Phase 2
- Anti-Scarring Efficacy and Safety of Intradermal Juvista (Avotermin) in Healthy MalesCompletedNCT00594581Phase 2